Significant treatment benefits seen at 18 months; in addition, risk for experiencing subsequent end points lower with valacyclovir. HealthDay News — One year of valacyclovir is beneficial for patients ...

Long-term, low-dose antiviral treatment opens doors for treating shingles in the eye. Will antiviral drug valacyclovir (Valtrex) be a game changer for eye disease? Long-term, low-dose antiviral ...

Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according to ...

Low-dose suppressive valacyclovir treatment of herpes zoster ophthalmicus (HZO) did not show significant benefits at 12 months but showed treatment superiority at 18 months and a reduction in the ...

STOCKHOLM--(BUSINESS WIRE)--Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 (valomaciclovir) in patients with shingles (herpes zoster) infection. The study's ...

Q: I’m a 64-year-old female with shingles. I have severe pain in the breastbone and back and a small rash under my breast. I cannot tolerate Valtrex, which fights the varicella-zoster virus that ...

There’s a potential new treatment for people who develop shingles that spread to the eye. Doctors say about 8% of shingles cases impact the eyes, and now, for the first time there’s a new treatment ...

Dr. Anne Oaklander answers the question: 'How Do I Prevent Shingles Pain?' — -- Question: Is There Anything I Can Do To Prevent Pain Associated With Shingles? Answer: Shingles is bad enough. Most ...

Inhibitex reported top-line safety and efficacy data from its Phase 2 clinical trial of FV-100 for the treatment of herpes zoster, more commonly referred to as shingles. The study included 350 ...